ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,560,591, issued on Feb. 24, was assigned to Providence Health & Services-Oregon (Portland, Ore.).

"Methods of treatment with CD8 T cell-mediated immune therapy" was invented by Kristina Young (Portland, Ore.) and Andrew Gunderson (Portland, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating a subject with cancer with CD8 T cell-mediated immune therapy are provided. The methods include measuring an amount of CXCR3-positive T cells in a peripheral blood sample or a tumor sample from a subject with cancer following treatment of the subject with at least one dose of the CD8 T cell-mediated therapy and comparing the amount of CXCR3-posit...